Reply to P. de Boissieu et al

被引：0

作者：

Birtle, Alison ^{[1
,2
,3
]}

Jones, Robert ^{[4
,5
]}

Cafferty, Fay H. ^{[6
]}

Biscombe, Katie ^{[6
]}

Hall, Emma ^{[6
]}

机构：

[1] Lancashire Teaching Hosp NHS Fdn Trust, Preston, England

[2] Univ Manchester, Manchester, England

[3] Univ Cent Lancashire, Preston, England

[4] Univ Glasgow, Glasgow City, Scotland

[5] Beatson West Scotland Canc Ctr, Glasgow City, Scotland

[6] Inst Canc Res, London, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 24期

关键词：

MEAN SURVIVAL-TIME; TRIALS;

D O I：

10.1200/JCO.24.00844

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 48 条

[21] REPLY: Potent P2Y12 Inhibitor Therapy for All?
Lau, Emily S.
O'Donoghue, Michelle L.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (11) : 1425 - 1426
[22] L'adoption des essais contrôlés randomisés entre norme institutionnelle, domination médicale et espoir de valorisation de la kinésithérapie
Rollin, Jeremy
REVUE D ANTHROPOLOGIE DES CONNAISSANCES, 2023, 17 (03):
[23] Culturally Fluent Theories, Metascience, and Scientific Progress: A Case Example: Commentary on Macnamara and Burgoyne (2023) and Burnette et al. (2023)
Oyserman, Daphna
PSYCHOLOGICAL BULLETIN, 2023, 149 (3-4) : 220 - 228
[24] Forum: the use of selective serotonin reuptake inhibitors in depressed children and adolescents: commentary on the meta-analysis by Hetrick et al.
Goodyer, Ian M.
Wilkinson, Paul
Dubicka, Bernadka
Kelvin, Raphael
CURRENT OPINION IN PSYCHIATRY, 2010, 23 (01) : 58 - 61
[25] Relevance of different results of different anti-double-stranded DNA assays in reporting clinical studies: comment on the article by Petri et al
Bonroy, Carolien
Verfaillie, Charlotte
De Witte, Evy
De Keyser, Filip
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (02) : 479 - 480
[26] Letter by van der Ende et al Regarding Article, "Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo"
van der Ende, Nadinda A. M.
Chalos, Vicky
Dippel, Diederik W. J.
STROKE, 2020, 51 (07) : E134 - E135
[27] Letter by Vester et al Regarding Article, "Hope Dies Last-Evidence Again Fails to Support a Neuroprotectant: Cerebrolysin for Acute Ischemic Stroke"
Vester, Johannes C.
Guekht, Alla
Heiss, Wolf Dieter
STROKE, 2017, 48 (12) : E365 - E365
[28] Reply to Amitha K Hewavitharana's Letter to the Editor re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine After Digital Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12-8
Jentzmik, Florian
Stephan, Carsten
Jung, Klaus
EUROPEAN UROLOGY, 2010, 58 (04) : E41 - E42
[29] Comment on "A primary care based healthy-eating and active living education session for weight reduction in the pre-diabetic population" by Daniala et al.
Gupta, Yashdeep
Singla, Rajiv
Kalra, Sanjay
PRIMARY CARE DIABETES, 2015, 9 (01) : 80 - 81
[30] Response to the Letter to the Editor " Reflections on a study of electroconvulsive therapy for clozapine-refractory schizophrenia" (Jolly et al. Schizophrenia Research, 267 (2024) 32-33)
Elkis, Helio
Correll, Christoph U.
Melzer-Ribeiro, Debora L.
SCHIZOPHRENIA RESEARCH, 2025, 276 : 15 - 16

← 1 2 3 4 5 →